|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net profit (loss) | |||||
| Adjustments to reconcile net profit (loss) to net cash provided by (used in) operating activities: | |||||
| Unrealized loss (gain) on foreign currency | |||||
| Provision for (benefit from) account receivable allowances | |||||
| Depreciation and amortization | |||||
| Amortization of capitalized internal-use software costs | |||||
| Amortization of deferred contract costs | |||||
| Remeasurement of convertible preferred share warrant liabilities | |||||
| Remeasurement of convertible preferred share tranche rights | |||||
| Impairment of deferred contract costs | |||||
| Share-based compensation expense | |||||
| Non-cash right-of-use asset changes | |||||
| Changes in accrued interest | |||||
| Ordinary share warrants issued to a customer | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Deferred contract acquisition costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation and benefits | |||||
| Guarantee obligations | |||||
| Provision for chargebacks, net | |||||
| Increase (Decrease) in Operating Lease Liability | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of short-term deposits | |||||
| Maturities of short-term deposits | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of fixed assets | |||||
| Capitalized software development costs | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of convertible preferred shares and warrants, net of issuance costs | |||||
| Proceeds from cash exercise of series E-1 convertible preferred share warrants | |||||
| Proceeds from exercise of share options | |||||
| Proceeds from initial public offering, net of underwriting discounts and commissions | |||||
| Payments of deferred offering costs | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Purchases of treasury shares | |||||
| Net cash provided by (used in) financing activities | |||||
| Effects of exchange rates on cash, cash equivalents, and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash—beginning of period | |||||
| Cash, cash equivalents, and restricted cash—end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of refunds received | |||||
| Payments for Rent | |||||
| Operating lease liabilities arising from obtaining right-of-use assets | |||||
| Adjustment to ROU assets upon modification of existing lease | |||||
| Supplemental disclosures of noncash investing and financing activities: | |||||
| Purchases of property and equipment during the period included in accounts payable and accrued expenses | |||||
| Share-based compensation capitalized for software development | |||||
| Software development costs, accrued but not paid | |||||
| Deferred offering costs accrued but not paid | |||||
| Settlement of convertible preferred share tranche rights | |||||
| Conversion of convertible preferred shares into Class A ordinary shares upon IPO | |||||
| Adjustments To Additional Paid In Capital, Reclassification Of Warrants, Including Portion Attributable To Temporary Equity | |||||
| Adjustments To Additional Paid In Capital, Elimination Of Par Value Upon Recapitalization | |||||
| Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...